Human medicines European public assessment report (EPAR): Ocrevus, ocrelizumab, Multiple Sclerosis, Date of authorisation: 08/01/2018, Revision: 14, Status: Authorised | Human medicines European public assessment report (EPAR): Ocrevus, ocrelizumab, Multiple Sclerosis, Date of authorisation: 08/01/2018, Revision: 14, Status: Authorised | | Human medicines European public assessment report (EPAR): Vaniqa, eflornithine, Hirsutism, Date of authorisation: 19/03/2001, Revision: 23, Status: Authorised | Human medicines European public assessment report (EPAR): Vaniqa, eflornithine, Hirsutism, Date of authorisation: 19/03/2001, Revision: 23, Status: Authorised | | |